M.A Postow, R. Sidlow, M.D Hellmann, 2018.
The wide range of immune-related adverse effects associated with immune checkpoint blockade can complicate this effective therapy and limit its use in patients with cancer. This review surveys the adverse effects and their management.
Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018). Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. The New England Journal of Medicine, 378(2), 158–168.
